Next Article in Journal
Can We Improve Pregnancy Rates in Hormone Receptor-Positive Breast Cancer After Endocrine Therapy? The Role of Fertility Preservation Beyond Gonadotoxic Therapy
Next Article in Special Issue
Real-World Experience with Approved CAR T-Cell Therapies Ciltacabtagene Autoleucel and Idecabtagene Vicleucel in 1272 Relapsed/Refractory Multiple Myeloma Patients
Previous Article in Journal
Immunotherapy Plus Surgery Improves Survival in Microsatellite Instability-High Colon Cancer with Isolated Peritoneal Metastases
Previous Article in Special Issue
Ibrutinib in Combination with Lenalidomide Revlimid/Dexamethasone in Relapsed/Refractory Multiple Myeloma (AFT-15)
 
 
Systematic Review

Article Versions Notes

Cancers 2025, 17(21), 3494; https://doi.org/10.3390/cancers17213494
Action Date Notes Link
article html file updated 2 September 2026 01:07 CEST Update https://www.mdpi.com/2072-6694/17/21/3494/html
article html file updated 30 October 2025 12:09 CET Original file -
article supplementary file uploaded. 30 October 2025 12:07 CET - https://www.mdpi.com/2072-6694/17/21/3494#supplementary
article pdf uploaded. 30 October 2025 12:07 CET Version of Record https://www.mdpi.com/2072-6694/17/21/3494/pdf
article xml uploaded. 30 October 2025 12:07 CET Update https://www.mdpi.com/2072-6694/17/21/3494/xml
article xml file uploaded 30 October 2025 12:07 CET Original file -
Back to TopTop